By Andrea Anderson

NEW YORK (GenomeWeb News) – The process of reprogramming mouse cells to produce induced pluripotent stem cells does not necessarily increase the risk of DNA rearrangement or retroelement transpositions, according to a study in the latest issue of Cell Stem Cell.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.